GPC5 and non-small cell lung carcinoma: Subsequently, we firstly demonstrated that GPC5 was generally downregulated in NSCLC, negatively correlated with lymph node metastasis and patients' prognosis, as well as suppressing the NSCLC invasion and migration in vitro [9].